Mehri S McKellar
Overview
Explore the profile of Mehri S McKellar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McKellar M, Keys J, Filiatreau L, McGee K, Kuruc J, Ferrari G, et al.
J Antimicrob Chemother
. 2024 Nov;
80(1):169-174.
PMID: 39504491
Background: Antiretroviral therapy (ART) is recommended for all individuals with HIV infection, including those with acute HIV-1 infection (AHI). While recommendations are similar to those for chronic infection, efficacy data...
2.
Chen H, Knettel B, Macon Harrison L, Marais A, Nelli A, Campbell H, et al.
N C Med J
. 2024 Sep;
84(5):335-341.
PMID: 39312782
Background: The COVID-19 pandemic has been a catalyst for telehealth services for people who use opioids; however, the data show dramatic increases in opioid overdose deaths and ongoing lack of...
3.
Stout J, Allamong M, Hung F, Link K, Chan C, Muiruri C, et al.
AIDS Behav
. 2024 Jul;
28(10):3315-3325.
PMID: 38954172
Long Acting Injectable (LAI) therapy to treat HIV is an alternative to daily oral medications. The success of early roll-out of LAI to eligible patients requires a better understanding of...
4.
Knettel B, Chen H, Wilson E, Agor D, McKellar M, Reif S
PLoS One
. 2024 Jun;
19(6):e0305174.
PMID: 38913659
Background: HIV, opioid use disorder (OUD), and mental health challenges share multiple syndemic risk factors. Each can be effectively treated with routine outpatient appointments, medication management, and psychosocial support, leading...
5.
McKellar M, Des Marais A, Chen H, Choi Y, Lilly R, Ayers D, et al.
Harm Reduct J
. 2024 Mar;
21(1):69.
PMID: 38532395
Background: People who inject drugs (PWID) are at high risk for opioid overdose and infectious diseases including HIV. We piloted PARTNER UP, a telemedicine-based program to provide PWID with medication...
6.
Burns C, Endres K, Derrick C, Cooper A, Fabel P, Okeke N, et al.
J Am Coll Clin Pharm
. 2023 May;
6(4):329-338.
PMID: 37251085
Introduction: HIV pre-exposure prophylaxis (PrEP) is largely underutilized in the Southern United States. Given their community presence, pharmacists are well positioned to provide PrEP within rural, Southern regions. However, pharmacists'...
7.
Krupp J, Hung F, LaChapelle T, Yarrington M, Link K, Choi Y, et al.
South Med J
. 2023 Apr;
116(4):333-340.
PMID: 37011580
Objectives: The opioid overdose epidemic is escalating. Increasing access to medications for opioid use disorder in primary care is crucial. The impact of the US Department of Health and Human...
8.
Corneli A, Perry B, Marais A, Choi Y, Chen H, Lilly R, et al.
Harm Reduct J
. 2022 Dec;
19(1):132.
PMID: 36463214
Background: People who inject drugs (PWID) are at risk for HIV and opioid overdose. We piloted PARTNER UP, a telemedicine-based program to provide PWID with access to both oral pre-exposure...
9.
Mitchell J, Burns C, Atkinson B, Cottrell M, Frye J, McKellar M, et al.
AIDS Behav
. 2022 May;
26(10):3325-3326.
PMID: 35507095
No abstract available.
10.
Burns C, Endres K, Farrow L, Mhina C, Cooper A, Silverberg B, et al.
Curr HIV Res
. 2022 Apr;
20(3):204-212.
PMID: 35473523
Background: Underutilization of HIV pre-exposure prophylaxis (PrEP) in the Southern United States (US) is well-documented. Urgent care (UC) centers are positioned as communityfacing access points to PrEP, but the feasibility...